Aerie Pharmaceuticals has entered into a lease agreement with IDA Ireland to establish a new manufacturing plant in the recently constructed 2,650m2 IDA Advanced Technology Building in Athlone, Ireland creating 50 new jobs.
The project, which is supported by IDA Ireland, will produce commercial supplies for the company’s product candidates Rhopress and Roclatan. Aerie is currently seeking approval for the products.
Aerie is a North Carolina-headquartered clinical-stage pharmaceutical company focused on the discovery, development and commercialisation of therapies for the treatment of patients with glaucoma and other eye diseases.
Aerie has commenced its design plan for the facility and expects to begin internal construction shortly. The company will initially create up to 50 new jobs in sterile manufacturing, quality, engineering and other support capabilities.
“We have now achieved another milestone in executing our stated long-term strategy. As we prepare for commercialisation, it is increasingly important that we ensure greater independence regarding our finished product sourcing while also meaningfully reducing our future product costs,”
Vicente Anido, Jr, Chief Executive and Chairman at Aerie.
Upload your CV to apply for as many jobs as you like.upload your CV